Clinical Trial Update: Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II [NA]

View source ↗

Summary

A clinical trial evaluating stereotactic ablative body radiotherapy with maintenance systemic therapy versus physician's choice of systemic therapy for oligopro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Breast Cancer, Metastatic, Metastatic Breast Cancer | NA | Status: NOT_YET_RECRUITING